Business Description
Chosa Oncology AB
ISIN : SE0007784319
Total Employee Number:
2Compare
Compare
Traded in other countries / regions
CHOSA.SwedenW5L.Germany IPO Date
2016-03-09Description
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -33.8 | |||||
3-Year EPS without NRI Growth Rate | 47 | |||||
3-Year FCF Growth Rate | -64.6 | |||||
3-Year Book Growth Rate | -28.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.04 | |||||
9-Day RSI | 49.05 | |||||
14-Day RSI | 48.61 | |||||
3-1 Month Momentum % | 12.44 | |||||
6-1 Month Momentum % | 1.32 | |||||
12-1 Month Momentum % | 37.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.28 | |||||
Quick Ratio | 3.28 | |||||
Cash Ratio | 2.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -57.2 | |||||
Shareholder Yield % | -10.08 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -6.62 | |||||
ROA % | -5.88 | |||||
ROIC % | -7.06 | |||||
3-Year ROIIC % | -64.2 | |||||
ROCE % | -10.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 3.15 | |||||
Price-to-Tangible-Book | 13.77 | |||||
Price-to-Operating-Cash-Flow | 111.15 | |||||
EV-to-EBIT | -36.96 | |||||
EV-to-EBITDA | -64.05 | |||||
EV-to-Forward-Revenue | 0.29 | |||||
EV-to-FCF | -14.78 | |||||
| Price-to-Net-Current-Asset-Value | 13.77 | |||||
| Price-to-Net-Cash | 20.65 | |||||
Earnings Yield (Greenblatt) % | -2.71 | |||||
FCF Yield % | -5.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chosa Oncology AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.007 | ||
| Beta | 0.9076 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.25 | ||
| Volatility % | 116.52 | ||
| 14-Day RSI | 48.61 | ||
| 14-Day ATR (kr) | 0.072364 | ||
| 20-Day SMA (kr) | 0.8637 | ||
| 12-1 Month Momentum % | 37.61 | ||
| 52-Week Range (kr) | 0.5 - 2.2 | ||
| Shares Outstanding (Mil) | 87.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chosa Oncology AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chosa Oncology AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-19 | In 138 days | ||
| Second quarter earnings results for 2026 | 2026-08-27 | In 54 days | ||
| First quarter earnings results for 2026 | 2026-05-30 | 0.75 (-11.79%) | ||
| General meeting for 2025 | 2026-05-27 10:00 | 0.75 (-0.27%) | ||
| Annual report for 2025 | 2026-05-06 | 0.89 (-6.30%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 0.85 (+18.88%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 1.21 (+6.14%) | ||
| Second quarter earnings results for 2025 | 2025-08-28 | 0.83 (-11.29%) | ||
| General meeting for 2024 | 2025-06-13 13:00 | 0.62 (-13.38%) | ||
| First quarter earnings results for 2025 | 2025-05-30 | 0.67 (+0.00%) |
Show
Entries
Chosa Oncology AB Frequently Asked Questions
What is Chosa Oncology AB(XSAT:CHOSA)'s stock price today?
The current price of XSAT:CHOSA is kr0.83. The 52 week high of XSAT:CHOSA is kr2.20 and 52 week low is kr0.50.
When is next earnings date of Chosa Oncology AB(XSAT:CHOSA)?
The next earnings date of Chosa Oncology AB(XSAT:CHOSA) is 2026-08-27.
Does Chosa Oncology AB(XSAT:CHOSA) pay dividends? If so, how much?
Chosa Oncology AB(XSAT:CHOSA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chosa Oncology AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers